Thursday, January 30, 2025
HomeTechnology23andme is exploring the strategic alternative, hoping to raise funds | Real...

23andme is exploring the strategic alternative, hoping to raise funds | Real Time Headlines

On Friday, March 10, 2023, in the southern (SXSW) Music Festival (SXSW) festival in the south of the southwest (SXSW) in the southwest (SXSW), Anne WOJCICKI was held on March 10, 2023, March 10, 2023 Essence

Jordan Vonderhaar (Jordan Vonderhaar) | Bloomberg | Getty image

Side Chu Ge’s Gene Testing Company 23andme Said on Tuesday, it has begun to explore Strategic substitution The second time may include selling companies or its assets, reorganization or business portfolio.

The stock lost 82 % of its value last year, fell 10 % in extended transactions, and stopped briefly.

The announcement coincides with the release of 23andme Results in the third quarterEssence The company’s consumer service business decreased by 8 % from $ 42.9 million in the same period last year to $ 39.6 million.

The company said it will “need extra liquidity” to fund its operations and want to raise funds.

23andme said in the revenue release on Tuesday: “Management has been determined, and there is a lot of doubt about the company’s ability to continue to worry about.”

CEO Anne Wojcicki try Keep the company floating. 23andme is now worth less than $ 100 million, which is less than $ 6 billion.

In March, 23andme’s independent directors established a special committee to evaluate the company’s potential ways. Wojcicki submitted a suggestion Private company In July, but Rejected Because it lacks promise financing and does not provide the closing stock price at that time, it Committee saidEssence

Two months later, independent directors resigned from the board of directors of 23andme, because the “company’s strategic direction” was related to Wojcicki. Since then, I appointed Wojcicki Three new independent directors In its board, 23andme also stated that it plans to reduce its labor force 40 % and close its treatment business as part of Reorganize plan.

23andme said on Tuesday that the Special Committee will once again supervise the search for strategic alternatives releaseEssence The committee chose Moelis & Company as its financial adviser, while Goodwin Proorter chose it as its legal adviser.

The committee said that transactions cannot be guaranteed. Wojcicki repeatedly stated that she wanted to privatize the company, but it was unclear whether she would submit another suggestion.

23andme did not immediately respond to CNBC’s comment request.

watch: The rise and fall of 23andme

The rise and fall of 23andme
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments